Dietary Seaweed and Early Breast Cancer: A Randomized Trial

Completed · Not applicable · Has a placebo group

Conditions studied: Seaweed Associated Changes in Healthy Subjects

In brief

Could daily consumption of seaweed help explain lower postmenopausal breast cancer (BC) incidence and mortality rates in Japan? This small proof of principle clinical trial was designed to test the idea that the same amount of seaweed normally eaten in Japan would induce metabolic changes when given to non-seaweed consuming healthy postmenopausal American women. The participants were given 10 capsules a day (about 1 tablespoon) for 3 months. During the first month the capsules contained placebo, the second month seaweed, and the third month placebo. We collected blood and urine samples after each treatment period and tested for changes in protein expression that might be related to consuming seaweed.

Key facts

Study ID
NCT01663792
Run by
University of South Carolina
People needed
15
Starts
2006-10-01
Expected to finish
2007-12-01
Last updated by the study team
2021-05-11

Who can join

Age: 45 and older, up to 68. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.